IFNB1 and tuberculosis: Treating mice with prostaglandin E2 and zileuton, which limit IFNβ induction, confers tolerance to Mtb [5] and zileuton has been developed as a drug that can be administered to TB patients to enhance the efficacy of antibiotic treatment [51].